Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Medical device for rheumatoid arthritis scheduled for October advisory panel review

Sep. 17, 1998

Advisory committee unanimously recommends approval for Enbrel

Sep. 17, 1998

Viragen acquires stake in Inflammatics; adds LeukoVAX to pipeline

Sep. 15, 1998

FDA approves, HMR begins shipping new treatment for adult rheumatoid arthritis

Sep. 14, 1998

Inhibitors of ICE activity described by Vertex

Sep. 14, 1998

Merck & Co. discovers another potent and selective COX-2 inhibitor

Sep. 11, 1998

Merck Frosst reveals discoveries in the field of COX-2 inhibitors at ACS meeting

Sep. 11, 1998

Kotobuki selects development candidate from novel series with selectivity for COX-2

Sep. 11, 1998

Merck's COX-2 inhibitor Vioxx shown safe and effective in clinical trials

Sep. 10, 1998

MMP inhibitor PGE-2946979 shows good oral antiarthritic activity in rats

Sep. 10, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Kymera’s IRF5 degrader shows potential in IBD treatment
BioWorld Science
At the recently concluded Digestive Disease Week, researchers from Kymera Therapeutics Inc. presented preclinical efficacy data on KT-579, a selective oral IRF5...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...